ALFA Finder India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold Telegram alerts alfafinder.com →
Thursday, 12 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Earnings Call

Jeena Sikho Lifecare Earnings Call: Key Takeaways

Jeena Sikho reported stellar FY26 growth, pivoting from government to high-margin private patients. Management used flamboyant, messianic rhetoric to mask ₹21cr in one-time expenses related to auditor-mandated accounting changes and staff bonuses.

Why this was an Alfa AlertManagement explicitly guided for PAT to grow 4x-5x over the next 4 years.
Highlights
Revenue growthRevenue rose 71% YoY to ₹801cr, driven by private hospital sales.
MarginsEBITDA margins jumped to 44% from 30% YoY due to efficiency.
Demand visibilityHigh; expanding beds from 2,300 to 10,000 to meet patient demand.
Management confidenceExtremely over-optimistic, bordering on messianic tone regarding 'revolutionizing' healthcare.

Growth

Revenue grew 71% YoY to ₹801cr. EBITDA margins expanded to 44% despite one-time hits.

Outlook

Targets 7,000-10,000 beds in 3-5 years and ₹300cr PAT for FY27.

Risks

One-time provisions of ₹21cr for lease adjustments and ESOPs suggest previous loose accounting.

Source

Earnings Call filed with NSE, NSE: JSLL. Summary written with AI assistance from the document.

Read the document ↗

Jeena Sikho Lifecare Limited: key numbers

Share price
₹367.95
Market cap
₹4,575 Cr
Revenue (annual)
₹801.4 Cr
Net profit (annual)
₹221.8 Cr
P/E (TTM)
19.3×Sector 43.8×
Promoter holding
63.67%+0.05% QoQ
FII holding
4.49%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Jeena Sikho Lifecare Limited

All →
18:12 IST NSE
Product Launch

Jeena Sikho Lifecare Product Launch

Jeena Sikho Lifecare Limited has launched eight new Ayurvedic healthcare, wellness, and nutraceutical products. These new offerings are now available in the domestic market.